(Q34444283)

2 August 2017

1 reference

title

Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion (English)

1 reference

2 August 2017

Fillmore HL

1

1 reference

2 August 2017

VanMeter TE

series ordinal

2

1 reference

2 August 2017

Broaddus WC

series ordinal

3

1 reference

2 August 2017

publication date

1 June 2001

1 reference

Journal of Neuro-Oncology

2 August 2017

published in

1 reference

2 August 2017

volume

53

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

187-202

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1012213604731

2 August 2017

exact match

0 references

cites work

Expression of the membrane-type 3 matrix metalloproteinase (MT3-MMP) in human brain tissues.

1 reference

12 December 2020

TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP.

1 reference

12 December 2020

Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors

1 reference

12 December 2020

Human membrane type-4 matrix metalloproteinase (MT4-MMP) is encoded by a novel major transcript: isolation of complementary DNA clones for human and mouse mt4-mmp transcripts.

1 reference

12 December 2020

Overview of matrix metalloproteinase expression in cultured human cells

1 reference

12 December 2020

Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas

1 reference

12 December 2020

Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells

1 reference

12 December 2020

Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors

1 reference

12 December 2020

Matrix metalloproteinases and their biological function in human gliomas

1 reference

12 December 2020

Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis.

1 reference

12 December 2020

Mechanisms of glioma invasion: role of matrix-metalloproteinases

1 reference

12 December 2020

Elevated expression of membrane type 1 metalloproteinase (MT1-MMP) in reactive astrocytes following neurodegeneration in mouse central nervous system

1 reference

12 December 2020

Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.

1 reference

12 December 2020

Matrix metalloproteinase-2 activation modulates glioma cell migration.

1 reference

12 December 2020

Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells

1 reference

12 December 2020

Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton

1 reference

12 December 2020

Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas

1 reference

12 December 2020

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas

1 reference

12 December 2020

TIMP-2 is required for efficient activation of proMMP-2 in vivo

1 reference

12 December 2020

Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter

1 reference

12 December 2020

Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro.

1 reference

12 December 2020

The propeptide domain of membrane type 1-matrix metalloproteinase acts as an intramolecular chaperone when expressed in trans with the mature sequence in COS-1 cells

1 reference

12 December 2020

Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA

1 reference

12 December 2020

cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment

1 reference

12 December 2020

The cytoplasmic carboxy-terminal amino acid determines the subcellular localization of proTGF-(alpha) and membrane type matrix metalloprotease (MT1-MMP)

1 reference

12 December 2020

Matrix metalloproteinases

1 reference

12 December 2020

MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover

1 reference

12 December 2020

Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion

1 reference

12 December 2020

Glioma invasion in the central nervous system

1 reference

12 December 2020

Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase.

1 reference

12 December 2020

Cell-extracellular matrix interaction in glioma invasion

1 reference

12 December 2020

A matrix metalloproteinase expressed on the surface of invasive tumour cells

1 reference

12 December 2020

Expression of timp-1, timp-2, 72-kda and 92-kda type-iv collagenase transcripts in human astrocytoma cell-lines - correlation with astrocytoma cell invasiveness

1 reference

12 December 2020

Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation.

1 reference

12 December 2020

Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression

1 reference

12 December 2020

Membrane-type metalloproteinases in tumor invasion

1 reference

12 December 2020

Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity

1 reference

12 December 2020

Genes of the membrane-type matrix metalloproteinase (MT-MMP) gene family, MMP14, MMP15, and MMP16, localize to human chromosomes 14, 16, and 8, respectively

1 reference

12 December 2020

Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family

1 reference

12 December 2020

Control of matrix metalloproteinase activity in cancer

1 reference

12 December 2020

Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.

1 reference

12 December 2020

Human membrane type-2 matrix metalloproteinase is defective in cell-associated activation of progelatinase A

1 reference

12 December 2020

Reduced angiogenesis and tumor progression in gelatinase A-deficient mice

1 reference

12 December 2020

Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C.

1 reference

12 December 2020

Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2.

1 reference

12 December 2020

Localization of the human membrane type 4-matrix metalloproteinase gene (MMP17) to chromosome 12q24.

1 reference

12 December 2020

Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I

1 reference

12 December 2020

Membrane type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain

1 reference

12 December 2020

Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

1 reference

12 December 2020

Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP)

1 reference

12 December 2020

Matrix metalloproteinases: effectors of development and normal physiology

1 reference

12 December 2020

Membrane type 1 matrix metalloproteinase-associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines

1 reference

12 December 2020

Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases

1 reference

12 December 2020

Leukolysin/MMP25/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage

1 reference

12 December 2020

Activated isoforms of MMP-2 are induced in U87 human glioma cells in response to beta-amyloid peptide

1 reference

12 December 2020

Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors

1 reference

12 December 2020

Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases

1 reference

12 December 2020

Expression of adhesion factors and degrading proteins in primary and secondary glioblastomas and their precursor tumors

1 reference

12 December 2020

Comparative analysis of matrix metalloproteinases by immunocytochemistry, immunohistochemistry and zymography in human primary brain tumours.

1 reference

12 December 2020

Furin-independent pathway of membrane type 1-matrix metalloproteinase activation in rabbit dermal fibroblasts

1 reference

12 December 2020

Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules

1 reference

12 December 2020

Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins

1 reference

12 December 2020

A transcriptional Map of the FMF region

1 reference

12 December 2020

Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate.

1 reference

12 December 2020

Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene.

1 reference

12 December 2020

Cell adhesion: old and new questions

1 reference

12 December 2020

Protein kinase C activation by phorbol ester increases in vitro invasion through regulation of matrix metalloproteinases/tissue inhibitors of metalloproteinases system in D54 human glioblastoma cells.

1 reference

12 December 2020

Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity

1 reference

12 December 2020

Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3.

1 reference

12 December 2020

Developmental regulation of membrane type-5 matrix metalloproteinase (MT5-MMP) expression in the rat nervous system.

1 reference

12 December 2020

Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors

1 reference

12 December 2020

Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2.

1 reference

12 December 2020

Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain

1 reference

12 December 2020

Heterogeneous regional expression patterns of matrix metalloproteinases in human malignant gliomas.

1 reference

12 December 2020

Membrane-type 6 matrix metalloproteinase (MT6-MMP, MMP-25) is the second glycosyl-phosphatidyl inositol (GPI)-anchored MMP

1 reference

12 December 2020

Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix.

1 reference

12 December 2020

Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases

1 reference

12 December 2020

Proteolysis and cell migration: creating a path?

1 reference

12 December 2020

Matrix metalloproteinases and diseases of the CNS.

1 reference

12 December 2020

Extracellular matrix-degrading proteinases in the nervous system

1 reference

12 December 2020

Mechanisms for pro matrix metalloproteinase activation.

1 reference

12 December 2020

Production of collagenase and inhibitor (TIMP) by intracranial tumors and dura in vitro

1 reference

12 December 2020

Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP.

1 reference

12 December 2020

Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts.

1 reference

12 December 2020

Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation

1 reference

12 December 2020

Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma

1 reference

12 December 2020

Extracellular matrix degradation by metalloproteinases and central nervous system diseases

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1012213604731

1 reference

Dimensions Publication ID

2 August 2017

1053575525

0 references

1 reference